BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld
BioWorld
June 18, 2003
View Archived Issues
MedImmune's Intranasal Vaccine FluMist Receives FDA Approval
MedImmune Inc. received long-awaited news late Tuesday afternoon as the FDA approved FluMist, a nasally delivered product that has ridden a rocky road throughout the regulatory review process. (BioWorld Today)
Read More
Cell Therapeutics, Novuspharma Merging In $236M Stock Exchange
Read More
Alcohol Abuse In Pregnancy Can Bring On Fetal Alcohol Syndrome, Mental Retardation In The Young
Read More
Biomira, Merck KGaA Report Failed Theratope Phase III Trial
Read More
BioMarin Aiming To Raise $125M In Convertible Notes
Read More
Questcor Raises $5M To Fund $18.2M Purchase Of Nascobal
Read More
Boston Life Sciences Plans Another Altropane Phase III
Read More
Amylin Sends Symlin Amendment To FDA, Seeks $150M In Notes
Read More
Other News To Note
Read More